Finance Lead, R&D

GLAUKOS - FINANCE LEAD, R&D

Location: Aliso Viejo, CA

How will you make an impact?
Glaukos is seeking a Finance Lead that will serve as a strategic partner to the R&D organization, delivering financial insights that support informed decision-making, effective resource allocation, and operational excellence. This role will oversee financial planning, reporting, and analysis while supporting initiatives that improve financial accuracy, efficiency, and visibility across the R&D portfolio. 

What will you do?

• Lead month-end close activities, quarterly forecasts, and annual planning for the global R&D function.
• Develop and maintain study-level financial trackers for budgets, spending, purchase commitments, invoices, and remaining funding.
• Prepare variance analyses and identify financial risks and opportunities.
• Partner with Accounting to ensure timely and accurate accruals.
• Provide financial guidance to department leaders on budgeting, forecasting, and resource allocation.
• Use analytics, automation, and visualization tools to improve reporting and decision support.
• Support business cases for strategic initiatives and product launches.
• Collaborate with teams across R&D, Operations, Supply Chain, Commercial, and Audit. 

How will you get here?

• Bachelor’s degree in Finance, Accounting, Data Science, or a related field.
• 5+ years of relevant finance experience.
• Experience developing complex financial models in Excel.
• Hands-on experience with Oracle, SAP, or a comparable ERP system.
• Medical device, pharmaceutical, or R&D finance experience preferred.
• Strong analytical, problem-solving, and communication skills.
• Ability to manage multiple priorities in a fast-paced environment.

Why Join Glaukos? Join a collaborative and innovative team where you can make a meaningful impact by providing financial insights that support strategic priorities, operational excellence, and continued growth.

#GKOSUS

Generous. Innovative. Leadership-driven. Family-oriented. Socially responsible. 

Founded in 1998, Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

Our mission at Glaukos is to truly transform vision by pioneering novel, dropless therapies that can meaningfully advance the standard of care and improve the lives of patients suffering from chronic, sight-threatening eye diseases. 

Innovation is at the core of everything we do, and we are resolute in our commitment to challenge conventional thinking with new treatment alternatives that are supported by real science, robust clinical evidence, and an unrelenting focus on patients. 

Our constant pursuit of game-changing technologies that disrupt legacy treatment paradigms is encapsulated in the Glaukos mantra “We’ll Go First,” which articulates our willingness to take chances, our determination to forge new ground, and our commitment to continuous improvement in all that we do.   

Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is in Aliso Viejo, California with additional locations in San Clemente, California, and Burlington, Massachusetts.

Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law. 

All offers of employment are contingent upon the successful completion of a background check, including successfully passing a drug screen, based on the position and local regulations.